Stevanato Group (NYSE:STVN) Given Equal Weight Rating at Morgan Stanley

Stevanato Group (NYSE:STVN)‘s stock had its “equal weight” rating reiterated by research analysts at Morgan Stanley in a research note issued on Monday, Benzinga reports. They currently have a $30.00 target price on the stock.

STVN has been the subject of a number of other research reports. BNP Paribas initiated coverage on Stevanato Group in a research note on Monday. They set an “outperform” rating for the company. Stephens reissued an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research report on Monday, March 25th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of €33.63 ($35.77).

Stevanato Group Price Performance

Shares of STVN stock opened at €27.22 ($28.96) on Monday. The firm has a fifty day simple moving average of €30.29 and a 200-day simple moving average of €29.48. Stevanato Group has a twelve month low of €23.00 ($24.47) and a twelve month high of €36.30 ($38.62). The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). The firm had revenue of €320.60 million during the quarter, compared to analysts’ expectations of €326.85 million. Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. The business’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 earnings per share. Equities analysts expect that Stevanato Group will post 0.67 EPS for the current year.

Institutional Investors Weigh In On Stevanato Group

Institutional investors have recently made changes to their positions in the company. SRS Capital Advisors Inc. boosted its holdings in Stevanato Group by 327.1% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,593 shares of the company’s stock worth $43,000 after purchasing an additional 1,220 shares during the period. PNC Financial Services Group Inc. acquired a new position in shares of Stevanato Group in the 3rd quarter valued at about $60,000. Fifth Third Bancorp grew its position in shares of Stevanato Group by 70.1% during the 3rd quarter. Fifth Third Bancorp now owns 2,473 shares of the company’s stock valued at $73,000 after buying an additional 1,019 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of Stevanato Group during the 3rd quarter valued at about $115,000. Finally, First Horizon Advisors Inc. raised its stake in Stevanato Group by 14.1% during the fourth quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock worth $145,000 after acquiring an additional 657 shares during the period.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.